24 May 2013
Keywords: watson, pays, 178m, novartis, headache, drugs, pharmaceuticals
Article | 27 January 2003
Watson Pharmaceuticals has said it will pay $178 million for the USrights to two product lines sold by Novartis for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 January 2003
23 May 2013
© 2013 thepharmaletter.com